title: New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients.
authors.affiliation: Department of Surgery, University of Pittsburgh, PA 15213.
authors.forename: V
authors.initials: V
authors.lastname: Scantlebury
authors.forename: R
authors.initials: R
authors.lastname: Shapiro
authors.forename: J
authors.initials: J
authors.lastname: Fung
authors.forename: A
authors.initials: A
authors.lastname: Tzakis
authors.forename: J
authors.initials: J
authors.lastname: McCauley
authors.forename: M
authors.initials: M
authors.lastname: Jordan
authors.forename: C
authors.initials: C
authors.lastname: Jensen
authors.forename: T
authors.initials: T
authors.lastname: Hakala
authors.forename: R
authors.initials: R
authors.lastname: Simmons
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D016572:Cyclosporine / Q000009:adverse effects* / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000209:etiology*; D006084:Graft Rejection; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D008775:Methylprednisolone / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D016572:Cyclosporine; D016559:Tacrolimus; D008775:Methylprednisolone